Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
2
users have commented on this narrative
42
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
KT
AN
AnalystLowTarget
Consensus Narrative from 25 Analysts
Shrinking Market Will Squeeze Margins Despite AI Upside
Key Takeaways Demographic decline and limited international exposure threaten KT's revenue growth, exposing it to domestic competition and economic challenges. Regulatory pressures, disruptive competitors, and high capital expenditures are expected to compress margins and strain profitability.
View narrative
₩51.40k
FV
8.4% overvalued
intrinsic discount
0.13%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 12 hours ago
author updated this narrative
SCHOTT Pharma KGaA
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
Intensifying Climate Mandates And Protectionism Will Erode Prospects
Key Takeaways Rising climate regulation, supply chain localization, and price competition threaten profitability and limit SCHOTT Pharma's access to key growth markets. Shifting pharmaceutical technologies and demographic changes risk reducing long-term demand for core injectable packaging, constraining future revenue expansion.
View narrative
€22.00
FV
3.6% overvalued
intrinsic discount
7.20%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 12 hours ago
author updated this narrative
EZTEC Empreendimentos e Participações
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
Aging Demographics And Rising Costs Will Hinder São Paulo Demand
Key Takeaways Demographic shifts, high interest rates, and regional concentration pose major risks to sales growth, earnings stability, and exposure to local downturns. Rising construction, labor, and compliance costs threaten profitability, potentially undermining returns and viability of future projects within the company's land portfolio.
View narrative
R$12.00
FV
19.5% overvalued
intrinsic discount
-5.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 11 hours ago
author updated this narrative
Imerys
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
EMILI Lithium And EV Demand Will Shape Future Markets
Key Takeaways Strategic focus on high-value, innovative materials and sustainability is fueling margin expansion and positioning for growth in EV and eco-friendly markets. Operational efficiencies, divestment of low-margin assets, and favorable trade policies are strengthening competitive standing and supporting robust profit and cash flow resilience.
View narrative
€28.40
FV
21.9% undervalued
intrinsic discount
3.58%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
1 day ago
author updated this narrative
Embecta
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
GLP-1 Partnerships Will Expand Global Healthcare Reach
Key Takeaways Strategic collaborations and product innovation position Embecta to capitalize on growing GLP-1 adoption and rising global diabetes prevalence, supporting durable revenue growth. Operational efficiencies, expanding into emerging markets, and improved financial flexibility enable Embecta to pursue growth while enhancing margins and shareholder value.
View narrative
US$16.67
FV
17.9% undervalued
intrinsic discount
-0.34%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
Updated
narrative
Haemonetics
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Aging Demographics Will Expand Global Plasma And Hemostasis Markets
Key Takeaways Accelerated innovation, portfolio transformation, and software adoption are driving share gains, margin expansion, and sustained revenue growth across both plasma and hospital markets. Demographic shifts and increased demand for blood management position core products for long-term growth, while targeted interventions aim to revitalize underperforming segments.
View narrative
US$78.64
FV
31.7% undervalued
intrinsic discount
2.52%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
3 days ago
author updated this narrative
Axos Financial
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Digital Banking And AI Investments Will Capture Emerging Loan Opportunities
Key Takeaways Emphasis on digital banking, AI-driven efficiencies, and niche lending supports strong, diversified growth while maintaining stable margins and operating leverage. Demographic trends and industry consolidation create new opportunities, enabling Axos to expand market share and enhance long-term revenue prospects.
View narrative
US$99.33
FV
11.3% undervalued
intrinsic discount
8.44%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
3 days ago
author updated this narrative
LEM Holding
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Fit For Growth Program And R&D Investments Will Strengthen Future Competitiveness
Key Takeaways Strategic expansion and R&D investments aim to improve competitiveness, revenue, and cost efficiency, enhancing margins and profitability. Growth in Chinese market shares, especially in automotive and renewable energy, is poised to elevate revenues and regional earnings.
View narrative
CHF 851.67
FV
34.0% undervalued
intrinsic discount
9.62%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
2 days ago
author updated this narrative
Eagers Automotive
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
Investment In Proprietary Technology Will Maintain Stable Net Margins Amid Economic Headwinds
Key Takeaways Eagers' transformation and technology investments boost employee productivity and help maintain stable margins, supporting earnings growth amid economic challenges. Strategic property acquisitions and efficient inventory management enhance financial stability and cost efficiency, positioning Eagers for substantial revenue and profit growth.
View narrative
AU$16.67
FV
27.3% overvalued
intrinsic discount
6.03%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
20
users have followed this narrative
18 days ago
author updated this narrative
Value any company in seconds
Popular companies